Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2025-12-25 @ 10:25 PM
Study NCT ID:
NCT01933958
Status:
COMPLETED
Last Update Posted:
2022-04-01
First Post:
2013-08-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Regorafenib Post-marketing Surveillance in Japan
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-04
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-29
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-29
First Submit QC Date:
None
Study First Post Date:
2013-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-21
Last Update Post Date:
2022-04-01
Last Update Post Date Type:
ACTUAL